Corteva, Inc.

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 1,454 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Announced separation, established from filings, not memory. On 1 October 2025 Corteva announced its intent to pursue a separation into two independent publicly traded companies, one for the Seed business and one for the Crop Protection business, subject to Board of Directors approval and required regulatory approvals; the transaction is intended to be a tax-free spin-off for U.S. federal income tax purposes (Q2 2026 10-Q, 'Recent Developments: Proposed Separation'). As of the Q2 2026 10-Q (period ended 30 June 2026, filed 31 July 2026) the separation was still described as 'intended' and 'proposed', not completed; the same 10-Q discloses that fourteen state attorneys general had threatened Corteva with potential actions to delay or prevent the separation over asset/liability allocation documentation. Subsequent 8-Ks confirm it remains PENDING as of 17 August 2026, not completed and not abandoned: the seed spinco is named Vylor Inc. (a wholly owned Corteva subsidiary); on 6 August 2026 Corteva announced Vylor commenced private note exchange offers conditioned on the Separation closing, and disclosed that 'as publicly announced by Corteva on July 30, 2026, the Separation is currently expected to be consummated on or about October 1, 2026, subject to satisfaction or waiver of the conditions thereto,' with Corteva's Board retaining discretion to abandon or alter the terms; on 14 August 2026 Corteva announced Vylor filed a Form 10 registration statement with the SEC covering Vylor's business ahead of the spin-off. No holding row is created for Vylor because the Separation is a spin-off of Corteva's own Seed business into a new public company distributed to Corteva shareholders, not a stake Corteva acquires in a third party; had it instead involved Corteva retaining an equity stake in Vylor post-separation, that stake would be recorded here as basis 'announced_transaction' and confidence 'contingent' per the brief, but no such retained-stake structure is disclosed in any filing reviewed.
• Holdings: none recorded, and why. Searched the Q2 2026 10-Q and FY2025 10-K for 'equity method', 'nonconsolidated affiliates', 'unconsolidated', 'joint venture', 'investment in', 'affiliate', 'noncontrolling', and 'equity in earnings'. Corteva discloses only a combined balance sheet line, 'Investment in nonconsolidated affiliates': $145 million at 30 June 2026, $160 million at 31 December 2025, $134 million at 30 June 2025 (Q2 2026 10-Q and FY2025 10-K balance sheets), covering an unspecified number of equity-method joint ventures and affiliates, none named. The FY2025 10-K's accounting-policy note states the company holds equity-method investments in affiliates over which it has significant influence but not control, including some joint ventures that are variable interest entities (VIEs) where Corteva is not the primary beneficiary, but names no individual investee or VIE. 'Equity in earnings (losses) of affiliates, net' was a net loss of $9 million (Q2 2026) and net income of $7 million (six months 2026) in the Other Income supplementary table, also not broken out by investee. The FY2025 10-K's Business risk factors also reference Corteva's 'Corteva Catalyst' platform for 'investments in strategic technologies' but discloses no investee names, share counts, or dollar amounts. Because the combined balance covers multiple unnamed investees, per the brief's rule against assigning a combined balance to one investee, no holding row is recorded; this is a sourced finding, not a gap from insufficient searching.
• Vanguard case: parent CIK 0000102909 filed Form 13F-NT (notice only, no holdings table, confirmed by inspecting the filing's own document index which contains only primary_doc.xml, no infotable) for the quarter ended 30 June 2026. Per the brief's Vanguard rule, this is the 13F-NT case: successor entities Vanguard Capital Management LLC and Vanguard Portfolio Management LLC ARE the position and are summed into one 'The Vanguard Group' row (73,596,074 shares). This is not the case where the parent itself files 13F-HR with holdings.
• Capital Group is three separate 13F filers per the brief. All three (Capital World Investors, Capital International Investors, Capital Research Global Investors) filed their own Q2 2026 13F-HR. Only Capital World Investors (CIK 0001422849) holds CTVA (42,923,729 shares); the other two were checked against both the issuer-name fragment 'CORTEVA' and the CUSIP fragment '22052L' and matched zero rows in either filing, confirmed not a spelling issue. The register's 'Capital Group' row is therefore the Capital World Investors position alone, named explicitly in its method_note, not a three-way sum.
• Proxy vs 13F reconciliation. Corteva's 2026 DEF 14A (record date 9 March 2026, ownership table dated 2 March 2026 except as noted) cites '5% or greater' holders sourced from stale Schedule 13G/A filings dated 13 February 2024 (data as of 31 December 2023): The Vanguard Group 80,338,904 shares (12.0%), BlackRock, Inc. 53,895,896 shares (8.0%), State Street Corporation 35,284,854 shares (5.3%). No Schedule 13D or 13G has been filed on CTVA common stock since 13 February 2024, per the EDGAR filing index for CIK 0001755672 (most recent SC 13G/A filings both dated 2024-02-13). The register instead uses each manager's Q2 2026 Form 13F-HR (30 June 2026 position date), which is more current: Vanguard's successor entities sum to 73,596,074 shares, BlackRock to 53,845,550 shares, and State Street to 38,261,197 shares, all somewhat below the stale 2023-year-end 13G figures, consistent with modest position trims over roughly two and a half years rather than a data error.
• Implied price-per-share check (value_usd / shares) across all twelve institutional register rows clusters tightly between $83.37 and $84.70, consistent with CTVA's 30 June 2026 price level; no row shows a ~1000x discrepancy, so no thousands-convention rescaling was needed.
• Wells Fargo & Company's Q2 2026 13F-HR reports 1,200,805 CTVA shares ($101,696,056), which would rank 13th by shares and is excluded from this top-12 register; it also reports a separate 4,000-share notional derivative line, excluded per the brief's derivative exclusion rule.
• Self-gate, computed as the chart computes it from this file: 14 register rows. Institutional rows (12, no rolls_up_into) sum to 328,635,866 shares. The Magro row (538,302 shares, rolls_up_into the group) counts at full value. The group aggregate row (1,027,751 shares, is_aggregate true) is reduced by the 538,302 shares that roll into it from Magro, contributing 489,449. Total = 328,635,866 + 538,302 + 489,449 = 329,663,617 shares against 667,196,000 shares outstanding = 49.41%. This is above the 25-45% expected band but inside the 15-55% band the brief treats as not obviously wrong; it reflects genuinely high concentration among CTVA's largest institutional holders (Vanguard alone is 11.0%) rather than a double-counted holder: every institutional row was independently sourced from a distinct filer's own 13F-HR with no shared CUSIP-line overlap, and the only container/member relationship in the file (Magro inside the 19-person group) is explicitly reduced.